Actemra 162 MG/0.9 ML syringe 0.9ML
Ended Awarded Last action
- Contract number
- SPE2DR26FCY1B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,501
Award facts
- Contract value 100% obligated
- $1,501.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded on January 7, 2026, to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA), covers the supply of Actemra 162 mg/0.9 mL syringes with a ceiling value of $1,501.48 and an ultimate completion date of January 8, 2026. The contract is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is located in Conshohocken, Pennsylvania, the company's headquarters. This delivery order is issued under AmerisourceBergen's parent company, Cencora, Inc.'s, significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2031, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal medical procurement vendor that supplies a comprehensive range of pharmaceutical products and medical supplies to military and veteran healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to fulfill diverse medical commodity requirements across multiple therapeutic domains, including specialty medications, vaccines, medical devices, and other healthcare commodities. The DLA Troop Support Medical IDC under which this delivery order falls enables the company to efficiently supply essential pharmaceutical materials to military treatment facilities and federal healthcare institutions globally, positioning AmerisourceBergen as a key logistics partner for the Department of Defense's medical supply chain.
Quick answers
Who was awarded contract SPE2DR26FCY1B?
SPE2DR26FCY1B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26FCY1B worth?
The government has obligated $1,501 on SPE2DR26FCY1B.
Is contract SPE2DR26FCY1B an order under another contract?
Yes. SPE2DR26FCY1B is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCY1B competed?
The extent of competition for SPE2DR26FCY1B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award